Literature DB >> 2166284

In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control.

D E Gunapala1, C A Facer, R Davidson, W R Weir.   

Abstract

Peripheral blood lymphocytes from healthy, Epstein-Barr virus (EB-virus)-seropositive donors and from patients with acute Plasmodium falciparum malaria were tested for their cytotoxicity towards autologous EB-virus-infected B-cells using an in vitro regression assay. Of the 18 cultures from control donors, 88.8% showed the normal pattern of regression. Of the 20 malaria patients in the study, 40% failed to exhibit the normal pattern observed in the control group. Analysis of the lymphocyte subsets showed a high incidence of inverted CD4:CD8 ratios in the patient group due to an absolute rise in the CD8 population. This data suggests that the immunosuppressive effects of acute malaria extend to defective control over EB-virus. The relevance of the observations to the aetiology of EB-virus-associated, endemic Burkitt's lymphoma (eBL) is discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2166284     DOI: 10.1007/BF00931060

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  20 in total

1.  Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.

Authors:  A B Rickinson; D Crawford; M A Epstein
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

Review 2.  Conditioned tumorigenicity of activated oncogenes.

Authors:  G Klein; E Klein
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

3.  T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria.

Authors:  H C Whittle; J Brown; K Marsh; B M Greenwood; P Seidelin; H Tighe; L Wedderburn
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

4.  Burkitt's lymphoma: clues to the role of malaria.

Authors:  M A Epstein
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

5.  Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients.

Authors:  D H Crawford; J M Edwards; P Sweny; A V Hoffbrand; G Janossy
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

6.  In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients.

Authors:  Q Y Yao; A B Rickinson; J S Gaston; M A Epstein
Journal:  Int J Cancer       Date:  1985-01-15       Impact factor: 7.396

7.  Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus.

Authors:  P K Kataaha; C A Facer; E J Holborow
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

8.  Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma.

Authors:  R H Morrow
Journal:  IARC Sci Publ       Date:  1985

9.  A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.

Authors:  T Sakane; H Kotani; S Takada; Y Murakawa; Y Ueda
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.

Authors:  D J Moss; S R Burrows; D J Castelino; R G Kane; J H Pope; A B Rickinson; M P Alpers; P F Heywood
Journal:  Int J Cancer       Date:  1983-06-15       Impact factor: 7.396

View more
  10 in total

Review 1.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.

Authors:  Ann M Moormann; Cynthia J Snider; Kiprotich Chelimo
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

3.  Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.

Authors:  Joshua M Obiero; Seif Shekalaghe; Cornelus C Hermsen; Maxmillian Mpina; Else M Bijker; Meta Roestenberg; Karina Teelen; Peter F Billingsley; B Kim Lee Sim; Eric R James; Claudia A Daubenberger; Stephen L Hoffman; Salim Abdulla; Robert W Sauerwein; Anja Scholzen
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

4.  Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin.

Authors:  A S Orago; C A Facer
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

5.  Denis Burkitt and the African lymphoma.

Authors:  I Magrath
Journal:  Ecancermedicalscience       Date:  2009-09-30

6.  Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.

Authors:  Cynthia J Snider; Stephen R Cole; Kiprotich Chelimo; Peter Odada Sumba; Pia D M Macdonald; Chandy C John; Steven R Meshnick; Ann M Moormann
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

7.  Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.

Authors:  Jennifer B Rosen; Joel G Breman; Charles R Manclark; Bruce D Meade; William E Collins; Hans O Lobel; Pierre Saliou; Jacquelin M Roberts; Pierre Campaoré; Mark A Miller
Journal:  Malar J       Date:  2005-11-06       Impact factor: 2.979

Review 8.  Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.

Authors:  Owain R Millington; Caterina Di Lorenzo; R Stephen Phillips; Paul Garside; James M Brewer
Journal:  J Biol       Date:  2006-04-12

9.  Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.

Authors:  Anja Scholzen; Diana Mittag; Stephen J Rogerson; Brian M Cooke; Magdalena Plebanski
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

10.  T-helper 1 versus T-helper 2 lymphocyte immunodysregulation is the central factor in genesis of Burkitt lymphoma: hypothesis.

Authors:  Joseph Lubega
Journal:  Infect Agent Cancer       Date:  2007-05-17       Impact factor: 2.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.